On 12 November 2025, Cosmoprof Asia officially opened in Hong Kong. As a leading Australian company in the health and beauty industry, Homart Group participated with its multi-brand portfolio, engaging global industry partners to explore the latest trends in health and beauty.

On the opening day, the Homart booth attracted strong attention from distributors, retailers, importers, cross-border e-commerce platforms, and industry media from around the world. The active discussions and continuous business enquiries reflected the growing international interest in wellness-driven beauty and high-quality Australian products.

During the exhibition, Homart showcased its innovation across health supplements, natural skincare, medical-grade beauty, and functional pet nutrition, highlighting Australia’s unique strengths in “nature + science.” Our onsite team provided product experience sessions, professional consultations, and market insights, helping global partners gain a deeper understanding of the potential of Australian health and beauty solutions.

Since its establishment in 1992, Homart has adhered to the brand philosophy of Health · Nature · Innovation. With multiple self-owned manufacturing facilities certified by TGA, cGMP, ISO, FDA and other international standards, Homart continues to bring trusted Australian-made products to markets worldwide.

Through this year’s Cosmoprof Asia, Homart further strengthened its global footprint in the health and beauty industry and looks forward to exploring new collaboration opportunities with international partners to drive the future of wellness and beauty.

The post Homart Group Shines at Cosmoprof Asia 2025 appeared first on Homart Pharmaceuticals.

At the expo, Homart and JD Health formalized a long-term strategic partnership focusing on flagship store operations, new product incubation, consumer education, and anti-counterfeiting traceability. The collaboration aims to strengthen brand building and service upgrades for Australian health products in China.

From left to right: Mr. John Madew, Senior Trade and Investment Commissioner and Deputy Consul-General; Ms. Lynn Yeh, CEO, Homart Group; the Hon Don Farrell, Australian Minister for Trade and Tourism; Ms. Changyue Song, Head of Cross-Border Business, JD Health; and Dr. Paul Grimes, CEO, Austrade.

From left to right: Ms. Lynn Yeh, CEO, Homart Group; Mr. Martin Ferreyra, Representative, Austrade; and Mr. Haohang Song, Vice President and General Manager of Nutrition and Health, JD Health.

In the presence of the Hon Don Farrell and Dr. Paul Grimes, CEO of Austrade, the strategic cooperation agreement was signed by Lynn Yeh, CEO of Homart Group, and Changyue Song, Head of Cross-border Business, JD Health. Lynn Yeh, Haohang Song, Vice President and General Manager of Nutrition and Health at JD Health, and Martin Ferreyra from Austrade jointly participated in the ribbon-cutting ceremony.

As Homart deepens its presence in China, it is also accelerating its global expansion. During the CIIE, Homart signed a strategic MOU with AliExpress, Alibaba Group’s international e-commerce platform, to strengthen collaboration in cross-border e-commerce, global marketing, and digital retail. The partnership aims to bring high-quality Australian-made health products to global consumers more efficiently.

The ribbon-cutting ceremony was attended by Lynn Yeh, CEO, Homart Group; Alfy Zhang, Country Manager for Australia and New Zealand, AliExpress; Martin Ferreyra from Austrade; and Ben Lazzaro, CEO, Australian Made.

From left to right: Ms. Lynn Yeh, CEO, Homart Group; Mr. Ben Lazzaro, CEO, Australian Made; Mr. Martin Ferreyra, Representative, Austrade; and Ms. Alfy Zhang, Country Manager for Australia and New Zealand, AliExpress.

Under the MOU, AliExpress will assist Homart in establishing an official flagship store on its platform, co-launching marketing and promotional campaigns, and enhancing customer experience. Homart, in turn, will provide high-quality, Australian-made health products with a stable and reliable supply chain.

The initial rollout will feature brands such as SpringLeaf, TopLife, GrandPawPaw, and CHÉRI, covering about 40 SKUs, with plans to expand to 200 SKUs within three years and reach cumulative sales of AUD 30 million.

As a long-time participant in the CIIE, Homart has witnessed the deepening cooperation between China and Australia in the health industry. Through its new partnerships with China’s leading e-commerce platforms, the company is building an international strategy centered on the Chinese market while advancing toward global expansion.

“CIIE is not just a showcase — it’s a bridge for collaboration,” said Lynn Yeh, CEO of Homart Group. “Through these partnerships, we hope to bring more premium Australian health products to China and the world. Homart will continue to leverage CIIE as a key platform to strengthen cooperation with partners in China and globally, contributing to a more open, innovative, and sustainable global health ecosystem.”

The post Australian Health Supplement Leader Homart Group Expands Global Footprint Through CIIE Partnerships with JD Health and AliExpress appeared first on Homart Pharmaceuticals.

Homart Group proudly participated in this grand event, presenting a selection of its trusted Australian brands — SpringLeaf, Little Innoscents, AUTILI, Thompson’s, Thursday Plantation, and Grandpawpaw. The showcased products covered diverse categories, ranging from natural nutrition to maternal and baby care, reflecting Homart’s commitment to Australian quality and global trust.

During the exhibition, Homart’s booth drew strong interest from Vietnamese families, distributors, and retail partners. After the exhibition, the Homart team also visited local pharmacies and mother & baby stores, witnessing how Homart products have already become part of everyday family life in Vietnam.

Homart will continue to uphold its philosophy of Health, Nature, and Innovation, bringing premium Australian-made products to more families around the world.

The post Homart Group Showcases at Vietbaby 2025 in Vietnam appeared first on Homart Pharmaceuticals.

During the exhibition, the Homart team conducted comprehensive product training sessions for Central Group’s sales and marketing teams, enhancing their understanding of Homart’s product portfolio and brand values. This hands-on collaboration further strengthened the partnership between the two companies and laid a solid foundation for expanding Homart’s presence in Thailand and the broader Southeast Asian market.

Vitafoods Asia 2025 brought together more than 600 exhibitors and over 13,000 visitors from around the world, serving as a premier international platform for innovation, networking, and collaboration in the nutraceutical industry.

The post Homart Strengthens Partnership with Central Group at Vitafoods Asia 2025 appeared first on Homart Pharmaceuticals.

Lynn Yeh, Founder and CEO of Homart Group, said:
“This partnership marks a major step in expanding PETMIMA’s presence in China. Together with Tongrentang and Huanshi, we will combine R&D, quality, and distribution strengths to bring trusted, science-based pet nutrition to more families.”

Through Tongrentang’s strong brand reputation and nationwide network, PETMIMA products will soon enter flagship and franchise stores across China.

As one of the world’s largest pet industry exhibitions, the 27th Asia Pet Fair gathered over 2,500 exhibitors and 120,000 industry professionals. PETMIMA’s participation showcased Australia’s excellence in pet nutrition innovation and strengthened the bridge between the Australian and Chinese health industries.

The post PETMIMA Signs Strategic Partnerships with Tongrentang and Shanghai Huanshi at Asia Pet Fair appeared first on Homart Pharmaceuticals.